44 results on '"Zalacaín R"'
Search Results
2. Capsular Polysaccaride Thickness Is an Essential Factor for the Antibiotic Response in Bacteremic Pneumococcal Pneumonia
- Author
-
Sanz, F., primary, Ruiz Iturriaga, L.A., additional, García Clemente, M.M., additional, España, P.P., additional, Serrano, L., additional, Carrión Collado, N., additional, Herrero Huertas, J., additional, Fernández-Fabrellas, E., additional, and Zalacaín, R., additional
- Published
- 2022
- Full Text
- View/download PDF
3. Early and Late Cardiovascular Events in Patients Hospitalized for Community-Acquired Pneumonia
- Author
-
Aldás I, Menéndez R, Méndez R, España PP, Almirall J, Boderías L, Rajas O, Zalacaín R, Vendrell M, Mir I, Torres A, and Grupo NEUMONAC
- Subjects
Cardiovascular events, Complicaciones, Complications, Eventos cardiovasculares, Mortalidad, Mortality, Neumonía, Pneumonia - Abstract
Community-acquired pneumonia increases the risk of cardiovascular events (CVE). The objective of this study was to analyze host, severity, and etiology factors associated with the appearance of early and late events and their impact on mortality.
- Published
- 2019
4. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome
- Author
-
Menéndez, R, Torres, A, Zalacaín, R, Aspa, J, Villasclaras, J J Martín, Borderías, L, Moya, J M Benítez, Ruiz-Manzano, J, de Castro, F Rodríguez, Blanquer, J, Pérez, D, Puzo, C, Gascón, F Sánchez, Gallardo, J, Álvarez, C, and Molinos, L
- Published
- 2004
5. Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study.
- Author
-
Torres, A, Dorca, J, Zalacaín, R, Bello, S, El-Ebiary, M, Molinos, L, Arévalo, M, Blanquer, J, Celis, R, Iriberri, M, Prats, E, Fernández, R, Irigaray, R, and Serra, J
- Published
- 1996
- Full Text
- View/download PDF
6. Liposarcoma mediastínico. A propósito de 2 casos
- Author
-
Ruiz, L.A., Camino, J., Cabriada, V., Campo, A., Pascal, I., and Zalacain, R.
- Published
- 1999
- Full Text
- View/download PDF
7. Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia
- Author
-
España PP, Capelastegui A, Quintana JM, Bilbao A, Diez R, Pascual S, Esteban C, Zalacaín R, Estelles A, and Torres A
- Subjects
macromolecular substances - Abstract
(1) To validate the Severe Community Acquired Pneumonia (SCAP) score in predicting 30-day mortality. (2) To validate its ability to identifying patients at low risk of death. (3) To compare it against the Pneumonia Severity Index (PSI), and the British Thoracic Society's CURB-65 rules.
- Published
- 2010
8. [Antimicrobial treatment of COPD in the elderly]
- Author
-
Torres Martí A, Ja, Quintano Jiménez, Martínez Ortiz de Zárate M, Carlos Rodriguez-Pascual, Prieto J, and Zalacaín R
- Subjects
Pulmonary Disease, Chronic Obstructive ,Humans ,Aged ,Anti-Bacterial Agents - Published
- 2006
9. Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome
- Author
-
Menéndez R, Torres A, Zalacaín R, Aspa J, Martín-Villasclaras JJ, Borderías L, Benítez-Moya JM, Ruiz-Manzano J, de Castro FR, Blanquer J, Pérez D, Puzo C, Sánchez-Gascón F, Gallardo J, Alvarez C, Molinos L, and NEUMOFAIL Group
- Abstract
Some studies highlight the association of better clinical responses with adherence to guidelines for empiric treatment of community-acquired pneumonia (CAP), but little is known about factors that influence this adherence.
- Published
- 2005
10. Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients
- Author
-
Menéndez R, Torres A, Rodríguez de Castro F, Zalacaín R, Aspa J, Martín Villasclaras JJ, Borderías L, Benítez Moya JM, Ruiz-Manzano J, Blanquer J, Pérez D, Puzo C, Sánchez-Gascón F, Gallardo J, Alvarez CJ, Molinos L, and Neumofail Group
- Subjects
respiratory tract diseases - Abstract
The natural history of the resolution of infectious parameters in patients with community-acquired pneumonia (CAP) is not completely known. The aim of our study was to identify those factors related to host characteristics, the severity of pneumonia, and treatment that influence clinical stability.
- Published
- 2004
11. Indicaciones y contraindicaciones de la fibrobroncoscopia
- Author
-
Pedrero, S., primary and Zalacaín, R., additional
- Published
- 2010
- Full Text
- View/download PDF
12. Diagnóstico y tratamiento de la neumonía nosocomial
- Author
-
Torres, A., primary, de Celis, M.R., additional, Bello, S., additional, Blanquer, J., additional, Dorca, J., additional, Molinos, L., additional, Verano, A., additional, and Zalacaín, R., additional
- Published
- 1997
- Full Text
- View/download PDF
13. Ácido peracético: alternativa a la esterilización de broncofibroscopios
- Author
-
Villate, J.I., primary, Barrón, J., additional, Zalacaín, R., additional, Urcelay, M.I., additional, Hernández, J.M., additional, and Argumedo, M., additional
- Published
- 1997
- Full Text
- View/download PDF
14. Requisitos mínimos para una unidad de endoscopia respiratoria. Área de Técnicas Diagnósticas y Terapéuticas
- Author
-
Canalis, E., primary, Castella, J., additional, Díaz, P., additional, Freixinet, J., additional, Rivas, J., additional, Zalacaín, R., additional, and Pac, J., additional
- Published
- 1997
- Full Text
- View/download PDF
15. Tumores bronquiales carcinoides. Análisis de 41 casos
- Author
-
Gómez, A., Zalacain, R., Cabriada, V., López, L., Cancelo, L., and Jaca, C.
- Published
- 2004
- Full Text
- View/download PDF
16. Neumonía en pacientes alcohólicos: características clínicas y etiológicas
- Author
-
Llorente, J.L., primary, Zalacaín, R., additional, Talayero, N., additional, Antoñana, J.M.a, additional, Sobradillo, V., additional, and Gaztelurrutia, L., additional
- Published
- 1994
- Full Text
- View/download PDF
17. [Guidelines for the diagnosis and management of community-acquired pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR)]
- Author
-
Inmaculada Alfageme, Aspa J, Bello S, Blanquer J, Blanquer R, Borderías L, Bravo C, de Celis R, de Gracia X, Dorca J, Gallardo J, Gallego M, Menéndez R, Molinos L, Paredes C, Rajas O, Rello J, Rodríguez de Castro F, Roig J, Sánchez-Gascón F, Torres A, Zalacaín R, and Infecciones Respiratorias -Separ, Grupo Estudio La Neumonía Adquirida En La Comunidad Area Tuberculosis E.
18. [Initial empirical antibiotic treatment of community-acquired pneumonia]
- Author
-
Frías J, Gomis M, Prieto J, Mensa J, Emilio Bouza, Ja, García-Rodríguez, Torres A, Dorca J, Zalacaín R, and García de Lomas J
- Subjects
Community-Acquired Infections ,Time Factors ,Risk Factors ,Pneumonia, Bacterial ,Humans ,Pneumonia, Pneumococcal ,Aged ,Anti-Bacterial Agents
19. Utilidad del lavado broncoalveolar en el paciente trasplantado renal con sospecha de infección respiratoria
- Author
-
Ruiz, L.A., Gil, R., Zalacain, R., Cabriada, V., Llorente, J.L., Barrón, J., and García-Riego, A.
- Published
- 1998
- Full Text
- View/download PDF
20. Infección y enfermedad pulmonar obstructiva crónica
- Author
-
Zalacain, R.
- Published
- 1998
- Full Text
- View/download PDF
21. El cepillado protegido bacteriológico en pacientes con EPOC severa
- Author
-
Zalacain, R., Achótegui, V., Pascal, I., Camino, J., Sobradillo, V., and Barrón, J.
- Published
- 1997
- Full Text
- View/download PDF
22. Neumonía adquirida en la comunidad. Fiabilidad de los criterios para decidir tratamiento ambulatorio
- Author
-
Zalacain, R., Talayero, N., Achótegui, V., Sobradillo, V., Corral, J., and Barreña, I.
- Published
- 1997
- Full Text
- View/download PDF
23. Tumoración cutánea como forma de presentación de la actinomicosis pulmonar
- Author
-
Gil, P., Ruiz, L.A., Pascal, I., Camino, J., Pocheville, I., and Zalacain, R.
- Published
- 1997
- Full Text
- View/download PDF
24. Diagnóstico y tratamiento de la neumonía adquirida en la comunidad
- Author
-
Dorca, J., coordinador, Bello, S., Blanquer, J., de Celis, R., Molinos, L., Torres, A., Verano, A., and Zalacain, R.
- Published
- 1997
- Full Text
- View/download PDF
25. Predictors of severe sepsis among patients hospitalized for community-acquired pneumonia
- Author
-
Beatriz Montull, Rosario Menéndez, Antoni Torres, Soledad Reyes, Raúl Méndez, Rafael Zalacaín, Alberto Capelastegui, Olga Rajas, Luis Borderías, Juan Martin-Villasclaras, Salvador Bello, Inmaculada Alfageme, Felipe Rodríguez de Castro, Jordi Rello, Luis Molinos, Juan Ruiz-Manzano, NAC Calidad Group, NAC Calidad Group, [Montull,B, Menéndez,R, Méndez,R] Pneumology Department, ISS/Hospital Universitario y Politecnico La Fe, CIBER Enfermedades Respiratorias (CIBERES), Valencia, Spain. [Torres,A] Pneumology Department, Hospital Clínico y Provincial,IDIBAPS, CIBER Enfermedades Respiratorias (CIBERES), Barcelona, Spain. [Zalacaín,R] Pneumology Department, Hospital Cruces, Vizcaya, Spain. [Capelastegui,A] Pneumology Department, Hospital Galdakao, Vizcaya, Spain. [Rajas,O] Pneumology Department, Hospital La Princesa, Madrid, Spain. [Borderías,L] Pneumology Department, Hospital San Jorge, Huesca, Spain. [Martín-Villasclaras,J] Pneumology Department, Hospital Carlos Haya, Malaga, Spain. [Bello,S] Pneumology Department, Hospital Miguel Servet, Zaragoza, Spain. [Alfageme,I] Pneumology Department, Hospital Valme, Sevilla, Spain. [Rodríguez de Castro,F] Pneumology Department, Hospital Doctor Negrin Las Palmas, Gran Canaria, Spain. [Rello,J] Critical Care Department, Hospital Joan XXII of Tarragona and Hospital Vall Hebron, Universtitat Autonoma de Barcelona, Barcelona, Spain. [Molinos,L] Pneumology Department, Hospital Central Asturias, Oviedo, Asturias, Spain. [Ruiz-Manzano,J] Pneumology Department, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain., This work was supported by PII (Programme of research of SEPAR) in respiratory infection, CIBERES (Centro de investigación en red de enfermedades respiratorias) an initiative of ISCIII (Instituto de Salud Carlos III), Beca Fis (PI04/1150), Beca SEPAR (Sociedad Española de Neumología y Cirugía torácica) (2006/0237) and Beca de la Consellería Sanitat Comunidad Valenciana (2007/0059)., Universidad de Sevilla. Departamento de Medicina, and Universitat de Barcelona
- Subjects
Male ,lcsh:Medicine ,Pneumònia ,Named Groups::Persons::Age Groups::Adult::Middle Aged [Medical Subject Headings] ,Severity of Illness Index ,Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings] ,0302 clinical medicine ,Community-acquired pneumonia ,Risk Factors ,Antibiotics ,Estudios prospectivos ,030212 general & internal medicine ,Prospective Studies ,Prospective cohort study ,Masculino ,lcsh:Science ,Microbiological studies ,Diseases::Bacterial Infections and Mycoses::Infection::Sepsis [Medical Subject Headings] ,Malalties pulmonars obstructives cròniques ,Diseases::Respiratory Tract Diseases::Lung Diseases::Pneumonia::Pneumonia, Viral [Medical Subject Headings] ,COPD ,Multidisciplinary ,Infecciones adquiridas en la comunidad ,Femenino ,Índice de la gravedad de la enfermedad ,Middle Aged ,CAP ,Humanos ,Community-Acquired Infections ,Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Prospective Studies [Medical Subject Headings] ,Female ,Diseases::Respiratory Tract Diseases::Lung Diseases::Pneumonia::Pneumonia, Bacterial [Medical Subject Headings] ,Research Article ,Factores de riesgo ,medicine.medical_specialty ,Neumonía bacteriana ,Pneumonia, Viral ,Anciano ,Check Tags::Male [Medical Subject Headings] ,Antibiòtics ,macromolecular substances ,Diseases::Bacterial Infections and Mycoses::Infection::Community-Acquired Infections [Medical Subject Headings] ,Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Statistics as Topic::Probability::Risk::Risk Factors [Medical Subject Headings] ,Sepsis ,03 medical and health sciences ,Internal medicine ,Severity of illness ,medicine ,Pneumonia, Bacterial ,Humans ,Health Care::Health Care Facilities, Manpower, and Services::Health Services::Patient Care::Hospitalization::Length of Stay [Medical Subject Headings] ,Septicèmia ,Named Groups::Persons::Age Groups::Adult::Aged [Medical Subject Headings] ,Chronic obstructive pulmonary diseases ,Aged ,Mediana edad ,business.industry ,Predictors ,lcsh:R ,Septicemia ,Pneumonia ,Length of Stay ,medicine.disease ,Severe sepsis ,Surgery ,Community acquired pneumonia ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Health Surveys::Health Status Indicators::Severity of Illness Index [Medical Subject Headings] ,030228 respiratory system ,Check Tags::Female [Medical Subject Headings] ,Bacteremia ,Etiology ,Neumonía vírica ,lcsh:Q ,business ,Duración de estancia hospitalaria - Abstract
PII (Programme of research of SEPAR) in respiratory infection; CIBERES (Centro de investigacion en red de enfermedades respiratorias) an initiative of ISCIII (Instituto de Salud Carlos III); Beca Fis [PI04/1150]; Beca SEPAR (Sociedad Espanola de Neumologia y Cirugia toracica) [2006/0237]; Beca de la Conselleria Sanitat Comunidad Valenciana [2007/0059], Montull, B., Menéndez, R., Torres, A., Reyes, S., Méndez, R., Zalacaín, R., Capelastegui, A., Rajas, O., Borderías, L., Martin-Villasclaras, J., Bello, S., Alfageme, I., De Castro, F.R., Rello, J., Molinos, L., Ruiz-Manzano, J., Aspa, J.
- Published
- 2016
26. Is the long-term mortality similar in COVID-19 and community-acquired pneumonia?
- Author
-
Méndez R, González-Jiménez P, Latorre A, Mengot N, Zalacain R, Ruiz LA, Serrano L, España PP, Uranga A, Cillóniz C, Hervás D, Torres A, Menéndez R, Pablo España P, Borderías L, Rajas O, Almirall J, Zalacaín R, Vendrell M, Bello S, Mir I, Morales C, Molinos L, Ferrer R, Briones M, Malo R, Sayago Reza I, Almonte Batista W, Moreno Galarraga L, Sibila Vidal O, Luis Rodríguez Hermosa J, Vargas Centanaro G, de Vega Sánchez B, Solís García E, Rodríguez Florez E, José M, Estaba C, Molina Molina M, Bordas J, Estela González Castro M, Badenes Bonet D, Domínguez Álvarez M, Pérez-Rodas EN, Marín Arguedas A, Román Bernal B, Estrada Trigueros G, Cuenca Peris S, Martín Royo M, Torres García M, Portillo Sánchez J, Lerenas Bernal F, Salome Ros Braquehais M, Alfonso García Guerra J, Dolores Martínez Pitarch M, Arroyo Fernández I, Guevara Velázquez V, Martínez Olondris P, Francisco Pereyra Barrionuevo M, Lázaro Sierra J, Clavería P, Luis Wangüemert Pérez A, Joel Ruiz Lacambra J, Fernández Ramos N, Guanche Dorta S, Macias Paredes A, de la Rosa Carrillo D, Palones Femenia E, Podzamczer Valls I, Peñacoba Toribio P, Muñoz Zara P, García García R, Del Mar Marrube Fernández M, Villar Aguilar L, de Jorge Domínguez Pazos S, Pereiro Brea T, Pando-Sandoval A, María García Clemente M, Alzueta Álvarez A, García Coya E, de Freitas González E, Pablo España Yandiola P, Uranga A, Raboso Moreno B, Panadero C, Abad A, Cano I, Pérez Orbis I, Gotera Rivera C, Ruiz Pérez C, Menéndez Villanueva R, Méndez R, Latorre A, González P, Ramírez Prieto T, Ángel Salvador Maya M, Valenzuela C, Cifrián Martínez JM, Marco Figueira Gonçalves J, Baeza Ruiz A, Expósito Marrero A, Gurbani N, Malo de Molina Ruiz R, Galdeano Lozano M, Villanueva Montes M, Toledo Pons N, Ramón Clar L, Esperanza Barrios A, Cejudo Ramos P, López Ramírez C, Gaboli M, Almadana Pacheco V, Eduard Barbé Illa F, Clara A, Gutiérrez González N, and Cabrera César E
- Abstract
Introduction: There are no data on the association of type of pneumonia and long-term mortality by the type of pneumonia (COVID-19 or community-acquired pneumonia [CAP]) on long-term mortality after an adjustment for potential confounding variables. We aimed to assess the type of pneumonia and risk factors for long-term mortality in patients who were hospitalized in conventional ward and later discharged., Methods: Retrospective analysis of two prospective and multicentre cohorts of hospitalized patients with COVID-19 and CAP. The main outcome under study was 1-year mortality in hospitalized patients in conventional ward and later discharged. We adjusted a Bayesian logistic regression model to assess associations between the type of pneumonia and 1-year mortality controlling for confounders., Results: The study included a total of 1,693 and 2,374 discharged patients in the COVID-19 and CAP cohorts, respectively. Of these, 1,525 (90.1%) and 2,249 (95%) patients underwent analysis. Until 1-year follow-up, 69 (4.5%) and 148 (6.6%) patients from the COVID-19 and CAP cohorts, respectively, died ( p = 0.008). However, the Bayesian model showed a low probability of effect (PE) of finding relevant differences in long-term mortality between CAP and COVID-19 (odds ratio 1.127, 95% credibility interval 0.862-1.591; PE = 0.774)., Conclusion: COVID-19 and CAP have similar long-term mortality after adjusting for potential confounders., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Méndez, González-Jiménez, Latorre, Mengot, Zalacain, Ruiz, Serrano, España, Uranga, Cillóniz, Hervás, Torres, Menéndez, NEUMONAC and RECOVID.)
- Published
- 2023
- Full Text
- View/download PDF
27. Early and Late Cardiovascular Events in Patients Hospitalized for Community-Acquired Pneumonia.
- Author
-
Aldás I, Menéndez R, Méndez R, España PP, Almirall J, Boderías L, Rajas O, Zalacaín R, Vendrell M, Mir I, and Torres A
- Subjects
- Aged, Cohort Studies, Humans, Prospective Studies, Cardiovascular Diseases epidemiology, Community-Acquired Infections epidemiology, Pneumonia epidemiology
- Abstract
Introduction: Community-acquired pneumonia increases the risk of cardiovascular events (CVE). The objective of this study was to analyze host, severity, and etiology factors associated with the appearance of early and late events and their impact on mortality., Method: Prospective multicenter cohort study in patients hospitalized for pneumonia. CVE and mortality rates were collected at admission, 30-day follow-up (early events), and one-year follow-up (late events)., Results: In total, 202 of 1,967 (10.42%) patients presented early CVE and 122 (6.64%) late events; 16% of 1-year mortality was attributed to cardiovascular disease. The host risk factors related to cardiovascular complications were: age ≥65 years, smoking, and chronic heart disease. Alcohol abuse was a risk factor for early events, whereas obesity, hypertension, and chronic renal failure were related to late events. Severe sepsis and Pneumonia Severity Index (PSI) ≥3 were independent risk factors for early events, and only PSI ≥3 for late events. Streptococcus pneumoniae was the microorganism associated with most cardiovascular complications. Developing CVE was an independent factor related to early (OR 2.37) and late mortality (OR 4.05)., Conclusions: Age, smoking, chronic heart disease, initial severity, and S. pneumoniae infection are risk factors for early and late events, complications that have been related with an increase of the mortality risk during and after the pneumonia episode. Awareness of these factors can help us make active and early diagnoses of CVE in hospitalized CAP patients and design future interventional studies to reduce cardiovascular risk., (Copyright © 2019 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
28. Predictors of Severe Sepsis among Patients Hospitalized for Community-Acquired Pneumonia.
- Author
-
Montull B, Menéndez R, Torres A, Reyes S, Méndez R, Zalacaín R, Capelastegui A, Rajas O, Borderías L, Martin-Villasclaras J, Bello S, Alfageme I, Rodríguez de Castro F, Rello J, Molinos L, and Ruiz-Manzano J
- Subjects
- Aged, Community-Acquired Infections microbiology, Female, Humans, Length of Stay, Male, Middle Aged, Pneumonia, Bacterial microbiology, Pneumonia, Viral virology, Prospective Studies, Risk Factors, Sepsis etiology, Sepsis mortality, Severity of Illness Index, Community-Acquired Infections complications, Pneumonia, Bacterial complications, Pneumonia, Viral complications, Sepsis epidemiology
- Abstract
Background: Severe sepsis, may be present on hospital arrival in approximately one-third of patients with community-acquired pneumonia (CAP)., Objective: To determine the host characteristics and micro-organisms associated with severe sepsis in patients hospitalized with CAP., Results: We performed a prospective multicenter cohort study in 13 Spanish hospital, on 4070 hospitalized CAP patients, 1529 of whom (37.6%) presented with severe sepsis. Severe sepsis CAP was independently associated with older age (>65 years), alcohol abuse (OR, 1.31; 95% CI, 1.07-1.61), chronic obstructive pulmonary disease (COPD) (OR, 1.75; 95% CI, 1.50-2.04) and renal disease (OR, 1.57; 95% CI, 1.21-2.03), whereas prior antibiotic treatment was a protective factor (OR, 0.62; 95% CI, 0.52-0.73). Bacteremia (OR, 1.37; 95% CI, 1.05-1.79), S pneumoniae (OR, 1.59; 95% CI, 1.31-1.95) and mixed microbial etiology (OR, 1.65; 95% CI, 1.10-2.49) were associated with severe sepsis CAP., Conclusions: CAP patients with COPD, renal disease and alcohol abuse, as well as those with CAP due to S pneumonia or mixed micro-organisms are more likely to present to the hospital with severe sepsis.
- Published
- 2016
- Full Text
- View/download PDF
29. Importance of Aspergillus spp. isolation in Acute exacerbations of severe COPD: prevalence, factors and follow-up: the FUNGI-COPD study.
- Author
-
Huerta A, Soler N, Esperatti M, Guerrero M, Menendez R, Gimeno A, Zalacaín R, Mir N, Aguado JM, and Torres A
- Subjects
- Acute Disease, Aged, Aged, 80 and over, Cohort Studies, Female, Follow-Up Studies, Humans, Male, Prevalence, Prospective Studies, Pulmonary Disease, Chronic Obstructive epidemiology, Risk Factors, Aspergillus isolation & purification, Pulmonary Disease, Chronic Obstructive diagnosis, Pulmonary Disease, Chronic Obstructive microbiology, Severity of Illness Index
- Abstract
Background: Acute exacerbations of COPD (AECOPD) are often associated with infectious agents, some of which may be non-usual, including Aspergillus spp. However, the importance of Aspergillus spp. in the clinical management of AECOPD still remains unclear., Objectives: The aims of the study were to analyze the prevalence and risk factors associated with Aspergillus spp. isolation in AECOPD, and to investigate the associated clinical outcomes during a 1-year follow-up period., Methods: Patients presenting with an AECOPD requiring hospitalization were prospectively included from four hospitals across Spain. Clinical, radiological and microbiological data were collected at admission and during the follow-up period (1, 6 and 12 months after discharge), and re-admissions and mortality data collected during the follow-up., Results: A total of 240 patients with severe AECOPD were included. Valid sputum samples were obtained in 144 (58%) patients, and in this group, the prevalence of Aspergillus spp. isolation was 16.6% on admission and 14.1% at one-year follow-up. Multivariate logistic-regression showed that AECOPD in the previous year (OR 12.35; 95% CI, 1.9-29.1; p < 0.001), concurrent isolation of pathogenic bacteria (OR 3.64; 95% CI 1.65-9.45, p = 0.001) and concomitant isolation of Pseudomonas aeruginosa (OR 2.80; 95% IC, 1.81-11.42; p = 0.001) were the main risk factors for Aspergillus spp. isolation., Conclusions: The main risk factors for Aspergillus spp. isolation were AECOPD in the previous year and concomitant isolation of Pseudomonas aeruginosa. However, although Aspergillus spp. is often isolated in sputum samples from patients with AECOPD, the pathogenic and clinical significance remains unclear.
- Published
- 2014
- Full Text
- View/download PDF
30. [Guidelines for the diagnosis and management of community-acquired pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR)].
- Author
-
Alfageme I, Aspa J, Bello S, Blanquer J, Blanquer R, Borderías L, Bravo C, de Celis R, de Gracia X, Dorca J, Gallardo J, Gallego M, Menéndez R, Molinos L, Paredes C, Rajas O, Rello J, Rodríguez de Castro F, Roig J, Sánchez-Gascón F, Torres A, and Zalacaín R
- Subjects
- Aged, Humans, Spain, Sputum chemistry, Anti-Bacterial Agents therapeutic use, Community-Acquired Infections drug therapy, Community-Acquired Infections microbiology, Community-Acquired Infections surgery, Gram-Negative Bacteria isolation & purification, Gram-Positive Bacteria isolation & purification, Health Services Administration, Pneumonia drug therapy, Thoracic Surgical Procedures methods
- Published
- 2005
31. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.
- Author
-
Rosell A, Monsó E, Soler N, Torres F, Angrill J, Riise G, Zalacaín R, Morera J, and Torres A
- Subjects
- Aged, Bacteria growth & development, Bacterial Infections complications, Bacterial Infections epidemiology, Bacterial Infections physiopathology, Bronchi microbiology, Bronchoscopy, Colony Count, Microbial, Disease Progression, Female, Forced Expiratory Volume, Haemophilus Infections complications, Haemophilus Infections epidemiology, Haemophilus Infections microbiology, Haemophilus Infections physiopathology, Haemophilus influenzae growth & development, Haemophilus influenzae isolation & purification, Humans, Male, Middle Aged, Odds Ratio, Prevalence, Pseudomonas Infections complications, Pseudomonas Infections epidemiology, Pseudomonas Infections microbiology, Pseudomonas Infections physiopathology, Pseudomonas aeruginosa growth & development, Pseudomonas aeruginosa isolation & purification, Pulmonary Disease, Chronic Obstructive complications, Pulmonary Disease, Chronic Obstructive physiopathology, Retrospective Studies, Risk Factors, Bacteria isolation & purification, Bacterial Infections microbiology, Pulmonary Disease, Chronic Obstructive microbiology, Sputum microbiology
- Abstract
Background: The culture of bronchial secretions from the lower airway has been reported to be positive for potentially pathogenic microorganisms (PPMs) in patients with stable chronic obstructive pulmonary disease (COPD), but the determinants and effects of this bacterial load in the airway are not established., Methods: To determine the bronchial microbial pattern in COPD and its relationship with exacerbation, we pooled analysis of crude data from studies that used protected specimen brush sampling, with age, sex, smoking, lung function, and microbiologic features of the lower airway as independent variables and exacerbation as the outcome, using logistic regression modeling., Results: Of 337 study participants, 70 were healthy, 181 had stable COPD, and 86 had exacerbated COPD. Differences in the microbial characteristics in the participating laboratories were not statistically significant. A cutoff point of 10(2) colony-forming units (CFU) per milliliter or greater for the identification of abnormal positive culture results for PPMs was defined using the 95th percentile in the pooled analysis of healthy individuals. Bronchial colonization of 10(2) CFU/mL or greater by PPMs was found in 53 patients with stable COPD (29%) and in 46 patients with exacerbated COPD (54%) (P<.001, chi(2) test), with a predominance of Haemophilus influenzae and Pseudomonas aeruginosa. Higher microbial loads were associated with exacerbation and showed a statistically significant dose-response relationship after adjustment for covariates (odds ratio, 3.62; 95% confidence interval, 1.47-8.90), but P aeruginosa persisted as a statistically significant risk factor after adjustment for microbial load (odds ratio, 11.12; 95% confidence interval, 1.17-105.82)., Conclusions: One quarter of the patients with COPD are colonized by PPMs during their stable periods. Exacerbation is associated with the overgrowth of PPMs and with the appearance of P aeruginosa in the lower airway, which is associated with exacerbation symptoms independent of load.
- Published
- 2005
- Full Text
- View/download PDF
32. [Community-acquired pneumonia due to Legionella pneumophila serogroup 1. Study of 97 cases].
- Author
-
Benito JR, Montejo JM, Cancelo L, Zalacaín R, López L, Fernández Gil de Pareja J, Alonso E, and Oñate J
- Subjects
- Acute Kidney Injury blood, Acute Kidney Injury etiology, Adult, Aged, Anti-Bacterial Agents, Antigens, Bacterial blood, Antigens, Bacterial urine, Community-Acquired Infections drug therapy, Community-Acquired Infections epidemiology, Community-Acquired Infections microbiology, Comorbidity, Creatine Kinase blood, Drug Therapy, Combination therapeutic use, Female, Humans, Incidence, Legionella pneumophila classification, Legionella pneumophila immunology, Legionella pneumophila pathogenicity, Legionnaires' Disease diagnosis, Legionnaires' Disease drug therapy, Legionnaires' Disease microbiology, Male, Middle Aged, Pneumonia, Bacterial drug therapy, Pneumonia, Bacterial epidemiology, Pneumonia, Bacterial microbiology, Prognosis, Retrospective Studies, Risk Factors, Smoking epidemiology, Spain epidemiology, Legionella pneumophila isolation & purification, Legionnaires' Disease epidemiology
- Abstract
Introduction: Legionella pneumophila is the causal agent of 5% to 12% of sporadic community-acquired pneumonia cases, though rates are changing with the use of new diagnostic methods., Methods: This is a retrospective study of all patients admitted to our hospital with community-acquired pneumonia due to Legionella pneumophila between 1997 and 2001. Diagnostic criteria included either a positive Legionella serogroup 1 urinary antigen test or seroconversion and a chest radiograph consistent with pneumonia., Results: A total of 97 patients were studied. Ninety cases (92.8%) were community-acquired and 7 (7.2%) were associated with travelling. In 82 cases (84.5%) the presentation was sporadic. Seventy-five patients were smokers (77.3%). The most common symptoms were fever in 91 patients (93.8%) and cough in 67 (68.1%). In five patients (5.2%) creatine phosphokinase concentrations were over 5 times their baseline values (in two over 100 times); four of these patients presented acute renal failure. Seroconversion was observed in 23/42 patients (54.8%). There were no statistically significant differences between the administration of erythromycin or clarithromycin in monotherapy, or in combination with rifampin. Nineteen patients (19.6%) presented acute renal failure and mechanical ventilation was necessary in 22 (22.7%). Twelve patients died (12.5%). Independent prognostic factors associated with death included respiratory rate > 30 breaths/min, urea > 60 mg/dL and PaO2 < 60 mmHg. A significant linear association was found between severity scale scores and the presence of complications or mortality., Conclusion: The Legionella urinary antigen test permits early diagnosis and treatment of this disease. The severity scale is an indicator of complications or death.
- Published
- 2003
33. [Diagnostic methods and treatment of community-acquired pneumonia in Spain: NACE study].
- Author
-
Celis MR, Torres A, Zalacaín R, Aspa J, Blanquer J, Blanquer R, Gallardo J, and España PP
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents therapeutic use, Community-Acquired Infections complications, Community-Acquired Infections diagnosis, Community-Acquired Infections drug therapy, Community-Acquired Infections microbiology, Community-Acquired Infections mortality, Female, Humans, Male, Middle Aged, Pneumonia, Bacterial complications, Pneumonia, Bacterial microbiology, Pneumonia, Bacterial mortality, Prospective Studies, Spain, Pneumonia, Bacterial diagnosis, Pneumonia, Bacterial drug therapy
- Abstract
Background: Community-acquired pneumonia (CAP) is one of the most frequent infectious disease conditions. With the aim of knowing the diagnostic and therapeutic strategies of CAP in Spanish hospitals we performed a prospective, observational and multicenter study., Patients and Method: Observational study of 468 patients with CAP consecutively evaluated in 21 Spanish hospitals. Clinical, diagnostic, therapeutic and evolutive variables were recorded., Results: We included 468 patients with a mean age of 63 (18) years; 75% of them had some comorbidity. 380 (81%) patients required hospitalization in a conventional ward while 19 (4%) were admitted in an Intensive Care Unit (ICU). 69 patients (15%) required ICU admission. During the first 24 h of admission, biochemical determinations were performed in 98% of cases, blood gas measurements in 88%, blood cultures in 265 (58%), sputum cultures in 149 (41%) and an invasive diagnostic technique was carried out in 17 cases. In 62 cases (14%), a microbiological diagnosis was achieved. Streptococcus pneumoniae (28 cases) was the most frequent isolate followed by Legionella pneumophila (6 cases). Clarithromycin was the most frequent antibiotic prescribed (38%), either as monotherapy (28) or in combination (148), followed by amoxicillin-clavulanate (124 cases). Nine percent of patients were considered non-responders to initial empirical antibiotic tretament. Overall mortality was 6% (25%) and it was significanty higher in non-responders., Conclusions: In most patients with CAP admitted in Spanish hospitals, a systematic diagnostic approach is lacking. There is an important variability in the administration of antimicrobials, the association of a betalactam plus clarithromycin being the most frequent strategy. Overall mortality is low and significantly higher in those patients with a lack of response to initial antibiotic treatment.
- Published
- 2002
- Full Text
- View/download PDF
34. [Initial empirical antibiotic treatment of community-acquired pneumonia].
- Author
-
Frías J, Gomis M, Prieto J, Mensa J, Bouza E, García-Rodríguez JA, Torres A, Dorca J, Zalacaín R, and García de Lomas J
- Subjects
- Aged, Anti-Bacterial Agents administration & dosage, Community-Acquired Infections diagnosis, Community-Acquired Infections drug therapy, Humans, Pneumonia, Bacterial complications, Pneumonia, Bacterial diagnosis, Pneumonia, Pneumococcal complications, Pneumonia, Pneumococcal diagnosis, Pneumonia, Pneumococcal drug therapy, Risk Factors, Time Factors, Anti-Bacterial Agents therapeutic use, Pneumonia, Bacterial drug therapy
- Published
- 1998
35. [Diagnosis and treatment of nosocomial pneumonia].
- Author
-
Torres A, de Celis MR, Bello S, Blanquer J, Dorca J, Molinos L, Verano A, and Zalacaín R
- Subjects
- Humans, Cross Infection diagnosis, Cross Infection therapy, Pneumonia diagnosis, Pneumonia therapy
- Published
- 1997
- Full Text
- View/download PDF
36. [Peracetic acid: alternative to the sterilization of bronchofibroscopes].
- Author
-
Villate JI, Barrón J, Zalacaín R, Urcelay MI, Hernández JM, and Argumedo M
- Subjects
- Evaluation Studies as Topic, Humans, Sterilization, Acinetobacter drug effects, Bronchoscopes, Disinfectants, Nontuberculous Mycobacteria drug effects, Peracetic Acid, Pseudomonas aeruginosa drug effects
- Abstract
The Steris system for cold sterilization with peracetic acid was evaluated by effecting a series of contaminations of a fiberoptic bronchoscope (FB) with specimens of Pseudomonas aeruginosa, Acinetobacter baumanii and Mycobacterium kansasi. The FB was contaminated 24 times, 8 times by each microorganism, using specimens containing more than 10(8) cfu/ml. After fixing the secretions on the FB and washing it with enzyme soap, the BF was sterilized. Specimens were taken for culturing after contamination of the FB, after washing, immediately after sterilization and 1 hour after sterilization. No microorganism growth of any of the samples was detected either immediately after sterilization or one hour later. Microbiological data confirmed contamination of the FB after aspiration and fixation of the inoculate. Chemical and biological tests with B. stearothermophilus spores as specified by the manufacturer were correct in all cases: 24 contaminations and 52 processes of prior training. The efficacy of washing with enzyme soap before sterilization stands out. In 14 of the 24 samples, culture was negative after washing and in 7 the concentration of microorganisms was less than 500 cfu/ml, which confirms the need for appropriate washing before any disinfection or sterilization process is begun. In conclusion, the Steris system based on peracetic acid is an alternative to other systems for cold sterilization or high level disinfection.
- Published
- 1997
- Full Text
- View/download PDF
37. [Minimal requirements for a respiratory endoscopy unit. Area of Diagnostic and Therapeutic Techniques of the Spanish Society of Pneumology and Thoracic Surgery].
- Author
-
Canalis E, Castella J, Díaz P, Freixinet J, Rivas J, Zalacaín R, and Pac J
- Subjects
- Bronchoscopes, Humans, Laser Therapy, Pulmonary Medicine instrumentation, Spain, Thoracoscopes, Bronchoscopy standards, Hospital Units standards, Pulmonary Medicine standards, Thoracoscopy standards
- Published
- 1997
- Full Text
- View/download PDF
38. [Pneumonia in alcoholic patients: the clinical and etiological characteristics].
- Author
-
Llorente JL, Zalacaín R, Gaztelurrutia L, Talayero N, Antoñana JM, and Sobradillo V
- Subjects
- Adult, Alcoholism epidemiology, Bacteria isolation & purification, Bacterial Infections drug therapy, Bacterial Infections epidemiology, Bacterial Infections etiology, Ceftriaxone administration & dosage, Clindamycin administration & dosage, Community-Acquired Infections diagnosis, Community-Acquired Infections drug therapy, Community-Acquired Infections epidemiology, Community-Acquired Infections etiology, Humans, Male, Middle Aged, Pneumonia drug therapy, Pneumonia epidemiology, Pneumonia etiology, Prospective Studies, Spain epidemiology, Alcoholism complications, Bacterial Infections diagnosis, Pneumonia diagnosis
- Abstract
Twenty-four alcoholic patients with community-acquired pneumonia were studied for 2 years in order to define clinical signs and etiology. Blood cultures and serological profiles were done for all patients in addition to standard blood analyses. All had an invasive procedure -transthoracic puncture with an ultrafine 25G needle (20 patients) or telescopic catheter with bacteriologic brush (4 patients). When we were unable to obtain a good sputum sample (5 patients), a culture was grown. The patients' mean age was 48 and 83% had an acute clinical profile (< or = 7 days with symptoms) with "typical" signs. The X-rays showed an alveolar pattern in all patients, with cavitation in 29%. Etiological diagnosis was reached in 17 (71%) cases, with St. Pneumoniae (25%), anaerobic microorganisms (20%) and C. burnetii (12.5%) being the germs found most frequently. The invasive techniques were more useful (54%) than the blood cultures (17%) or sputum cultures (4%), and they were well tolerated and uncomplicated. Empirical antibiotic treatment was modified for 12 patients (50%). Seventeen percent required intensive care treatment and mortality was 12.5%.
- Published
- 1994
- Full Text
- View/download PDF
39. [Current use of penicillin in community-acquired pneumococcal pneumonias].
- Author
-
Gaztelurrutia L, Zalacaín R, Rubio G, Hernández JL, Urra E, Hernández M, Garea C, and Barrón J
- Subjects
- Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents, Bacteremia microbiology, Community-Acquired Infections drug therapy, Community-Acquired Infections epidemiology, Community-Acquired Infections microbiology, Drug Therapy, Combination therapeutic use, Drug Utilization, Female, Humans, Male, Middle Aged, Penicillin Resistance, Pneumonia, Pneumococcal epidemiology, Pneumonia, Pneumococcal microbiology, Prevalence, Retrospective Studies, Risk Factors, Spain epidemiology, Streptococcus pneumoniae drug effects, Streptococcus pneumoniae isolation & purification, Treatment Outcome, Penicillins therapeutic use, Pneumonia, Pneumococcal drug therapy
- Abstract
Background: A retrospective study was performed to know the clinical and microbiologic aspects of community-acquired pneumococcal pneumonia in adult patients admitted to a general hospital from 1990-1992., Methods and Results: The medical records of 55 patients, aged 20-86 years (man age: 58 year) were reviewed. Streptococcus pneumoniae was isolated from blood in 45 cases (81.8%), transparietal lung puncture in 5 (9.1%), pleural fluid 3 (5.5%) and protected specimen brushing (> 1,000 UFC/ml) in 2 (3.6%) Most isolated (80%) were sensitive to penicillin (CIM < 0.1 microgram/ml); intermediate (CIM > or = 0.1 microgram/ml) 9 (16.4%) and resistant (> 1 microgram/ml) 2 (3.6%). Underlying diseases were present in 39 (70.9%) cases. All patients received empiric treatment with one or more antibiotics effective against Streptococcus pneumoniae. Only in 2 of the 9 cases treated with erythromycin the microorganism was resistant to this drug. Eleven patients died (20%), 5 died before to the fifth day of admission. Mortality was influenced by involvement of 2 or more lobes and immunosuppression (p < 0.05)., Conclusions: This study suggests that 80% of the community-acquired pneumococcal pneumonia in a population with a high prevalence rate of disease requiring hospital admission are very sensitive in vitro to penicillin in contrast with its seldom clinical use in the authors environment. No microorganism presented with CIM above 2 micrograms/ml. Mortality was not due to inadequate therapy but rather to the severity of the underlying disease.
- Published
- 1994
40. [Clinical and etiological features of community-acquired pneumonia in the elderly].
- Author
-
Llorente JL, Zalacaín R, Gaztelurrutia L, Talayero N, Pérez M, Badiola C, and Sobradillo V
- Subjects
- Aged, Aged, 80 and over, Bacteria isolation & purification, Biopsy, Needle, Ceftriaxone therapeutic use, Community-Acquired Infections drug therapy, Community-Acquired Infections epidemiology, Community-Acquired Infections microbiology, Female, Hospitalization, Humans, Male, Pneumonia drug therapy, Pneumonia microbiology, Prospective Studies, Spain epidemiology, Pneumonia epidemiology
- Abstract
Background: The aim of the present study was to know the clinical and etiologic features of community-acquired pneumonia (CAP) in elderly patients requiring hospital admission., Methods: A prospective study of 36 consecutive patients aged over 70 years, admitted to a general hospital was performed. Standard analytical determinations, blood cultures, and serologic studies were performed in all patients using invasive techniques: aspirative transthoracic puncture (ATP) with ultrafine needle in 35 (97%) cases, and telescopic catheter (TC) in 1 case., Results: The mean age was 79 years (range: 71-90). Twenty-two patients had received antibiotic treatment prior to admission (61%) and 17 (47%) presented chronic debilitating diseases. The clinical characteristics of CAP were "typical" with acute presentation in most. Fifteen cases (42%) were etiologically diagnosed and the most frequently isolated agents were Streptococcus pneumoniae (22%) and Haemophilus influenzae (8%). Empiric treatment was changed on the basis of isolations in 7 cases (19%). Eight patients died (22%)., Conclusions: According to our results community-acquired pneumonia in the population studied: 1) generally showed an acute presentation with "typical" characteristics, carrying a high mortality rate (22%), 2) is of bacterial etiology, with S. pneumoniae and H. influenzae being the most frequently isolated microorganisms, 3) the use of ATP in community-acquired pneumonia offers a high diagnostic effectiveness, good tolerance and low risk of complications.
- Published
- 1994
41. [Transthoracic aspiration punction with ultrafine needle in high risk community acquired pneumonia].
- Author
-
Zalacaín R, Llorente JL, Gaztelurrutia L, Zenarruzabeitia E, Uresandi F, and Sobradillo V
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Pneumonia microbiology, Prospective Studies, Punctures methods, Risk Factors, Sensitivity and Specificity, Thorax, Needles, Pneumonia diagnosis, Punctures instrumentation, Suction instrumentation
- Abstract
Background: The identification of etiologic agents of pneumonias acquired in the community (PAC) with risk factors is difficult. The classical diagnostic methods are not profitable and thus invasive techniques are used. In this study the diagnostic use of an invasive technique such as aspirative transthoracic puncture (ATP) was evaluated in this type of pneumonias., Methods: In 94 patients of high risk suspect of PAC the ATP was carried out. This was performed with an ultrafine needle (25G) without radioscopic control. In all cases blood cultures, serology (Legionella, Mycoplasma pneumoniae, Coxiella burnetti, Chlamydia psittaci) were performed when atypical clinical manifestations were presented and sputum examination (Gram, Ziehl, culture) was undertaken when possible., Results: The sensitivity of ATP was 36% and increased to 54.6% in cases previously untreated with antibiotics. Specificity was 96.4%. The sensitivity of blood culture was 8% and sputum 13.6%. ATP was well tolerated in 97.9% with complication in only 4 (4.3%). The results of ATP led to changes in treatment in 23.1% of the cases with definitive diagnosis of pneumonia., Conclusions: Aspirative transthoracic puncture with ultrafine needle without fluoroscopic control was a very well tolerated technique with a minimum number of complications, easy to perform at the patients bedside and was used to modify treatment in 23.1% of the cases.
- Published
- 1993
42. [Tuberculosis and AIDS. Study of 54 patients].
- Author
-
Aguirrebengoa L, Montejo M, Urkijo JC, Urra E, Gutiérrez A, Mendoza F, Zalacaín R, González de Zárate P, and Aguirre C
- Subjects
- Acquired Immunodeficiency Syndrome mortality, Antitubercular Agents therapeutic use, Comorbidity, Humans, Immunocompromised Host, Incidence, Life Tables, Opportunistic Infections epidemiology, Patient Compliance, Prevalence, Retrospective Studies, Spain epidemiology, Substance Abuse, Intravenous epidemiology, Tuberculosis drug therapy, Tuberculosis mortality, Acquired Immunodeficiency Syndrome epidemiology, Tuberculosis epidemiology
- Abstract
We present 54 cases of tuberculosis (TBC) and Acquired Immunodeficiency Syndrome (AIDS) that were observed during five years and represent 37% of our AIDS patients. TBC was diagnosed before AIDS in 7, after AIDS in 5 and simultaneously in 42. Eighty-seven per cent were intravenous drug users (IVDU) and no hemophilia cases were recorded. The tuberculin skin test (PPD) showed a reaction greater than 5 mm in 43%. Prophylaxis has not been used in any patient. TBC was localized in 39% and disseminated in 61%; the lung was the main organ involved. Diagnosis was established by culture in 42 cases and by pathology exam in 12 cases. Eighteen patients had multiple isolations, while 36 had a single one. Co-occurrence with other opportunistic infections was observed in 27 cases. Death related to TBC was seen in 3 patients, and there were no differences in survival between disseminated and localized presentations. Compliance of treatment was very low and follow-up was not achieved in large number of patients.
- Published
- 1991
43. [Evaluation of bronchoalveolar lavage in the microbiological diagnosis of pneumonia in patients at risk].
- Author
-
Gaztelurrutia L, Barrón J, Zalacaín R, Rubio G, Urra E, Sánchez I, Urzay L, and Sainz de Rozas R
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Evaluation Studies as Topic, Female, Humans, Male, Middle Aged, Pneumonia microbiology, Predictive Value of Tests, Prospective Studies, Risk Factors, Bronchoalveolar Lavage Fluid microbiology, Pneumonia diagnosis
- Abstract
Bronchoalveolar washout was performed in 130 patients with pneumonia during a period of 28 months. Microbiological investigation involved common bacteria, Legionella, fungi, viruses (Cytomegalovirus, herpes, RSV), Mycobacterium, and Pneumocystis carinii. Infection HIV was present in 75% of patients. The remaining patients had malignant diseases or severe pneumonia. The overall sensitivity of the technique was 65.4% and the positive predictive value was 92%. The technique was less sensitive in cases of bacterial pneumonia (sensitivity = 34.4%). This was attributed to the fact that 82.8% of these cases received antibiotic therapy. Pneumocystis carinii and Mycobacterium tuberculosis were the most common agents (44.8% and 34.5%, respectively). In seven instances the clinical picture was related to cytomegalovirus, although this diagnosis can not be easily done.
- Published
- 1991
44. [Bronchoconstriction caused by pressurized aerosol].
- Author
-
Sobradillo V and Zalacaín R
- Subjects
- Adult, Bronchial Provocation Tests, Humans, Male, Aerosol Propellants adverse effects, Aerosols adverse effects, Bronchial Spasm chemically induced
- Published
- 1987
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.